Nlife Therapeutics

Oligonucleotide-based therapies for Parkinsons's disease and other CNS disorders

placeArmilla, Andalusia, Spain calendar_todayFounded 2010 groups17 employees language n-life.es

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital4100%
Coming soon